Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Merck
McKinsey
Medtronic
Johnson and Johnson

Last Updated: January 29, 2022

DrugPatentWatch Database Preview

Ic Targets Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for IC TARGETS, and what generic and branded alternatives to IC TARGETS drugs are available?

IC TARGETS has one approved drug.



Summary for Ic Targets
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Ic Targets

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Ic Targets

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 4,647,447 ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 5,223,243 ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 4,933,456 ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 4,992,554 ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 5,091,169 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Baxter
Harvard Business School
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.